Fidson Pharmaceuticals Secures Global License to Produce Generic Influenza Antiviral
Fidson Pharmaceuticals has been chosen to manufacture a generic influenza antiviral as part of a global initiative aimed at increasing access to essential medicines. This development positions Nigeria among a select group of countries participating in a worldwide health effort to combat influenza outbreaks.
The Abuja Times

Nigerian pharmaceutical company Fidson has been selected to produce a generic version of an influenza antiviral medication under a global licensing agreement. This initiative is part of a broader effort to enhance access to essential medicines across various countries, including Nigeria, which has been identified as a key player in the pharmaceutical landscape.
The global initiative involves manufacturers from several countries such as Brazil, China, India, Indonesia, Malaysia, Uganda, Ukraine, and Vietnam, highlighting a collaborative international approach to addressing public health challenges. By participating in this program, Fidson not only strengthens Nigeria's role in the global pharmaceutical market but also aims to improve local healthcare outcomes in the fight against influenza.
“This selection underscores the capability of Nigerian drug manufacturers to contribute significantly to global health initiatives,” said a representative from Fidson Pharmaceuticals.
The decision to include Fidson in the manufacturing process comes at a critical time when access to effective antiviral treatments is paramount, especially in low and middle-income countries. The production of this generic antiviral is expected to reduce costs and improve availability, thereby potentially saving countless lives during influenza outbreaks.
As the world continues to grapple with various health crises, including the recent COVID-19 pandemic, this development serves as a reminder of the importance of local manufacturing capabilities and international cooperation in the healthcare sector. Fidson's involvement in this global licensing project is a significant step forward in ensuring that essential medicines are accessible to all.
Share this article with your network
Broadcast directly to WhatsApp communities and news circles.
The Abuja Morning Dispatch
Get the capital's most important political investigations, cabinet decisions, and economic intelligence delivered to your inbox every morning.
About The Abuja Times
Super Admin & Lead Director
Related Dispatches in Business
Abia State Allocates ₦1.04 Billion for SME Growth and Reviews ASEPA Workers' Remuneration
In a strategic move to bolster the state's economy, the Abia State Government has approved ₦1.041 billion to support small and medium-scale enterprises (SMEs) while also revising the pay structure for ad-hoc workers at the Abia State Environmental Protection Agency (ASEPA). This funding initiative aims to enhance business operations and create sustainable jobs across the region.
Cooking Gas Prices Surge by 14% Amid Supply Shortages in Nigeria
The price of cooking gas in Nigeria has surged to N1,600 per kilogram in November 2026, reflecting a 14% increase from the previous month. Industry experts warn that ongoing supply shortages are exacerbating the crisis, calling for urgent infrastructure improvements.
Governor Mbah Launches Premium Trust Bank in Enugu, Highlights Economic Growth
Governor Mbah inaugurated a new branch of Premium Trust Bank in Enugu, emphasizing the role of security and infrastructure in attracting investments. He expressed hopes for the establishment of up to ten bank branches as economic activities flourish in the region.




